Treatment with anti-TIMP1 decreased the levels of plasma TIMP1 by 10-fold in UTI mice, in addition to lowering the levels of G-CSF (CSF3, 14-fold) as compared to the IgG control, confirming a co-regulation of circulating factors that respond to UTI (Supp. Here, TIMP1 is linked to bacterial urinary tract infection.